Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Ptc Therapeutics
(NQ:
PTCT
)
33.43
-0.50 (-1.47%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Ptc Therapeutics
< Previous
1
2
3
4
5
6
Next >
Untapped Potential: 3 Stocks Tackling the Toughest Rare Diseases
August 25, 2023
Treating rare diseases is a tough but potentially lucrative business. With clinical trials coming due, here are three stocks to buy.
Via
InvestorPlace
Where PTC Therapeutics Stands With Analysts
August 07, 2023
Via
Benzinga
Raymond James Maintains Outperform Rating for PTC Therapeutics: Here's What You Need To Know
August 04, 2023
Via
Benzinga
Earnings Scheduled For August 3, 2023
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
Where PTC Therapeutics Stands With Analysts
July 20, 2023
Via
Benzinga
Morgan Stanley Maintains Equal-Weight Rating for PTC Therapeutics: Here's What You Need To Know
July 11, 2023
Via
Benzinga
What 15 Analyst Ratings Have To Say About PTC Therapeutics
June 30, 2023
Via
Benzinga
14 Analysts Have This to Say About PTC Therapeutics
May 24, 2023
Via
Benzinga
The Latest Analyst Ratings for PTC Therapeutics
May 08, 2023
Via
Benzinga
PTC Therapeutics's Return On Capital Employed Insights
May 04, 2023
Via
Benzinga
PTC Therapeutics' Seizure Study Fails To Meet Primary Goal, Analyst Says Minimal Impact On Investment Thesis
June 30, 2023
PTC Therapeutics Inc (NASDAQ: PTCT) said its MIT-E trial of vatiquinone for mitochondrial disease-associated seizures (MDAS) failed to achieve its primary endpoint of
Via
Benzinga
PTC Therapeutics Says Interim Data For Huntington's Disease Candidate Shows Promise In Mid-Stage Study
June 21, 2023
PTC Therapeutics Inc (NASDAQ: PTCT) shared interim data from the 12-week portion of the PIVOT-HD Phase 2 study of PTC518 in
Via
Benzinga
3 High-Potential Small-Cap Stocks for Investors With Strong Stomachs
May 31, 2023
Small-cap stocks can be risky, and all three of these companies are facing adversity. But they could be home run investments.
Via
InvestorPlace
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against PTC Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
May 24, 2023
From
The Schall Law Firm
Via
Business Wire
Why America's Car-Mart Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 24, 2023
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares jumped 209.1% to $0.5622 after the United States Patent and Trademark Office granted the company a patent for certain medical systems and methods.
Via
Benzinga
PTC Therapeutics Stock Tumbles: Company Stops Preclinical Gene Therapy Programs After Failed Friedreich's Ataxia Study
May 24, 2023
Via
Benzinga
Dow Falls Over 100 Points; Analog Devices Posts Upbeat Q2 Earnings
May 24, 2023
U.S. stocks traded lower this morning, with the Dow Jones dropping over 100 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.44% to 32,908.94 while the NASDAQ fell...
Via
Benzinga
Why Is Apexigen (APGN) Stock Up 31% Today?
May 24, 2023
Apexigen (APGN) stock is rising higher on Wednesday following news of a $16 million acquisition deal with Pyxis Oncology (PYXS).
Via
InvestorPlace
Why Is Ocugen (OCGN) Stock Down 22% Today?
May 24, 2023
Ocugen (OCGN) stock is falling on Wednesday after the pharmaceutical company revealed details of a public offering for its shares.
Via
InvestorPlace
Why Is PTC Therapeutics (PTCT) Stock Down 21% Today?
May 24, 2023
PTC Therapeutics (PTCT) stock is taking a beating on Wednesday after the company provided investors with an update on a clinical trial.
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
May 24, 2023
Via
Benzinga
Why Inovio Pharmaceuticals Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
May 24, 2023
Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 202.3% to $0.5499 in pre-market trading. Minerva Surgical was granted U.S. Patent #11653972 for "Medical Systems And Methods (For Resecting And...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
May 24, 2023
It's time for a dive into the biggest pre-market stock movers as we check out all of the latest news for Wednesday morning!
Via
InvestorPlace
Agilent, PTC Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
May 24, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against PTC Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
May 23, 2023
From
The Schall Law Firm
Via
Business Wire
PTC Therapeutics Takes Investors On A Ride With A Failed Study, Scrapped Programs, Ousted CFO
May 23, 2023
PTC announced a barrage of news, starting with a failed Phase 3 study.
Via
Investor's Business Daily
Chart Of The Day: PTC Therapeutics
May 18, 2023
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for patients with rare disorders.
Via
Talk Markets
Palo Alto Networks To Rally Around 21%? Here Are 10 Other Analyst Forecasts For Thursday
May 18, 2023
Needham raised the price target for Dynatrace, Inc. (NYSE: DT) from $52 to $56. Needham analyst James Ricchiuti maintained a Buy rating. Dynatrace shares gained 1.9% to $47.95 in pre-market trading.
Via
Benzinga
Why PTC Therapeutics Could Be Victorious In Its Rare-Disease Battle Against BioMarin Pharmaceuticals
May 17, 2023
The company is working on a treatment for PKU, a disorder that can lead to intellectual disabilities.
Via
Investor's Business Daily
Earnings Scheduled For April 27, 2023
April 27, 2023
Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is expected to report earnings for its first quarter.
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.